After exposure to CCL18 for 12 hr, the N-Ras/ERK/PI3K/AKT signaling pathway in breast cancer cells is activated and triggers activation of NFκB, which is the central mediator for the maintenance of EMT in vivo and in vitro. This evidence concerns the gene AKT1 and breast cancer.